Streetbeat News

Regulatory

GM

GM's self-driving unit, Cruise, will pay a $500,000 fine for submitting a false crash report after a robotaxi accident in San Francisco. The incident involved a pedestrian being injured by a Cruise vehicle.

Portfolio Pulse from

November 15, 2024 | 7:30 am

DMXCF

District Metals Corp. has provided an update on the Swedish Parliament's discussions regarding the uranium moratorium, which is significant for the company due to its ownership of the Viken Energy Metals Deposit in Sweden, one of the largest uranium and vanadium deposits globally.

Portfolio Pulse from

November 15, 2024 | 7:15 am

ANPCY

ANGLE plc has announced the presentation of new data on its Parsortix-based PD-L1 assay at the AACR conference. This assay allows for the monitoring of PD-L1 status in lung cancer patients, potentially advancing personalized treatment.

Portfolio Pulse from

November 15, 2024 | 7:15 am

MSFT

Elon Musk has added Microsoft to a lawsuit against OpenAI, accusing the AI start-up of undermining antitrust law. This legal action could have implications for Microsoft's involvement with OpenAI.

Portfolio Pulse from

November 15, 2024 | 7:15 am

SDZNY

Sandoz has received European Commission approval for Afqlir® (aflibercept), a biosimilar to Eylea®, to treat retinal diseases. This strengthens Sandoz's biosimilar portfolio and reinforces its leadership in the global and European markets.

Portfolio Pulse from

November 15, 2024 | 6:15 am

REGN

Regeneron Pharmaceuticals and Sanofi announced that the FDA has accepted the resubmission of the sBLA for Dupixent to treat chronic spontaneous urticaria (CSU). If approved, it would be the first targeted therapy for CSU in a decade, with a decision expected by April 18, 2025.

Portfolio Pulse from

November 15, 2024 | 6:15 am

REGN

The FDA has accepted the resubmission of the supplemental biologics license application for Dupixent to treat chronic spontaneous urticaria. This could make Dupixent the first targeted therapy for CSU in a decade, with a decision expected by April 18, 2025.

Portfolio Pulse from

November 15, 2024 | 6:15 am

SPGI

COP29 discussions are centered on the international community's reaction to the U.S. election, with S&P Global highlighting potential increased tensions between the U.S. and China.

Portfolio Pulse from

November 15, 2024 | 6:00 am

MCHI

The iShares MSCI China ETF (MCHI) is facing mixed impacts from Beijing's economic stimulus and potential tariff threats from Trump's re-election campaign. While China's stimulus has positively influenced MCHI, the anticipation of Trump's re-election and associated tariffs pose a risk. MCHI's performance is significantly tied to domestic consumption, with consumer cyclicals comprising 31% of the ETF.

Portfolio Pulse from

November 15, 2024 | 5:15 am

CVX

California officials have concluded the spill response at Chevron's Richmond Wharf port facility, but an investigation into the incident will continue.

Portfolio Pulse from

November 15, 2024 | 4:15 am